Abstract
The objective of present study was to formulate mouth dissolving tablets of Zolmitriptan. Zolmitriptan is a 5-HT receptor agonist. It is used in the treatment of migraine. Six different formulations of Zolmitriptan mouth dissolving tablets were prepared by using direct compression technique by using different concentrations of ACDi-Sol, Avicel pH 101 and strlac. Tablets were evaluated for different precompression and post compression parameters of tablets were carried out and the results satisfies according to the pharmacopoeia specifications. Other parameters such as drug-excipients compatibility were also evaluated through IR and DSC study. IR and DSC studies revelled that there is no interaction between drug and different excipients used in formulation. Formulation F6 was selected as optimised formulation showing better dissolution results at 35 minutes.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
